In Indispensible Parameters of Pitavastatin Include Symptoms, Mechanism of Action, Administration, Adverse Effect, Contraindications, Toxicity and Enhancing Health Care Team Outcomes

Pitavastatin is a medication used to treat and control hypercholesterolemia and dyslipidemia. It is a member of the class of drugs called statins. The action, indications, and contraindications of pitavastatin as a helpful drug for the treatment of dyslipidemia are explained in this activity. The mechanism of action, adverse event profile, dosage, pharmacokinetics, monitoring, and relevant interactions will be highlighted in this session to assist interprofessional team members in managing patients with dyslipidemia and related disorders.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-07-28
DOI
https://doi.org/10.5281/zenodo.21636640
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In Indispensible Parameters of Pitavastatin Include Symptoms, Mechanism of Action, Administration, Adverse Effect, Contraindications, Toxicity and Enhancing Health Care Team Outcomes

Madhavi Latha C, Sony Sharlet E., Muralinath E., Karthik Jayanth Y. et al.
Zenodo (CERN European Organization for Nuclear Research)
Lipoproteins and Cardiovascular Health
article

In Indispensible Parameters of Pitavastatin Include Symptoms, Mechanism of Action, Administration, Adverse Effect, Contraindications, Toxicity and Enhancing Health Care Team Outcomes

Madhavi Latha C, Sony Sharlet E., Muralinath E., Karthik Jayanth Y., Sheethal U., Guruprasad M., Ramadevi Ch., Renuka. U.
article en

Abstract

Pitavastatin is a medication used to treat and control hypercholesterolemia and dyslipidemia. It is a member of the class of drugs called statins. The action, indications, and contraindications of pitavastatin as a helpful drug for the treatment of dyslipidemia are explained in this activity. The mechanism of action, adverse event profile, dosage, pharmacokinetics, monitoring, and relevant interactions will be highlighted in this session to assist interprofessional team members in managing patients with dyslipidemia and related disorders.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 7%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.